Navigation Links
Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance
Date:4/24/2008

-- Received FDA clearance for new MRSA diagnostic test to protect hospital

patients

-- First Fisher Scientific Chinese-language catalog introduced to serve

those markets

"We delivered excellent financial performance in the quarter, with a 25% increase in adjusted EPS and 140 basis points of adjusted operating margin expansion even though our growth was somewhat affected by having fewer days in the quarter," said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. "Recognizing that there is economic uncertainty in the world today, we remain confident that our balanced mix of markets, geographies, products and services puts us in a strong position to deliver on our financial goals for 2008.

"We announced a number of new developments in the quarter that fortify our position as the world leader in serving science. Under our Thermo Scientific brand, we launched exciting new instrumentation that simplifies sophisticated analytical technologies so non-experts can use them for a broader range of applications. We also introduced a new siRNA platform that allows life sciences researchers to study more cell types in their quest to develop better treatments for disease. In addition, our new MRSA diagnostic test is designed to make it easier for doctors to screen patients for staph infection when they are admitted to the hospital. Finally, we published our first Fisher Scientific catalog in Chinese to make our broad portfolio of laboratory supplies available to more customers in that growing market."

Mr. Dekkers added, "Primarily as a result of more favorable currency translation, we are raising our revenue guidance for the year and now expect to report full year 2008 revenues in the range of $10.6 to $10.7 billion, resulting in 9 to 10% growth over 2007. The revenue increase also leads us to raise our adjusted EPS guidance for 2008 by $0.02, to a range of $3.07 to $3.17. This would result in 1
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Thermo Fisher Scientific to Present at Upcoming Investor Conferences
2. Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 24, 2008
3. Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008
4. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
5. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
6. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
7. Thermo Fisher Scientific to Webcast Press Conference at PITTCON 2008
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
11. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... -- According to a new market ... by Type (Monoclonal, Polyclonal), by Technology (Hybridoma), by ... Analysis & Global Forecast to 2019", published by ... Market for the forecast period of 2014 to ... Billion by 2019 from $1.425 Billion in 2014, ...
(Date:4/30/2015)... Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research ... $4.4 million, compared to $8.0 million during the same period ... was $8.9 million, or $0.23 per basic and diluted share. ... period in 2014, of $8.7 million, or $0.27 per basic ... cash equivalents and investments totaled $117.5 million. , "During ...
(Date:4/30/2015)... Cambridge, MA & Budapest, Hungary (PRWEB) April 30, ... the only web-based electronic lab notebook with integrated ... leader in providing chemistry software solutions and consulting ... that led to the development of Labguru’s newest ... a set of deep domain features for biologists, ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Labguru Integrates ChemAxon's Marvin JS, to Enhance Functionality for Chemists 2
... The New Jersey Board of,Pharmacy has ... pharmacy,technicians at Wedgewood Pharmacy. The program was ... Affairs Department. Upon,completion of the program, each ... high level of competence in all state ...
... ORLANDO, Fla., Sept. 7 Daniel B. Yarosh, ... keynote presentation at the 11th,Annual Sunscreen Symposium today ... 6th-9th) of cosmetic chemists is sponsored by the,Florida ... Yarosh will,present "Beyond Sunscreens: DNA Repair and Photoaging" ...
... Genmab Announces ofatumumab Appeared More Effective Than rituximab ... ... Genmab A/S,(OMX: GEN) announced today that ofatumumab (HuMax-CD20(R)) appeared ... mechanism, than rituximab in a pre-clinical study. The CD20,antibodies were ...
Cached Biology Technology:NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 3AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 2Genmab Announces Encouraging Preclinical Data for ofatumumab 2
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/6/2015)... 6, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND ... NXT-ID introduces a new revolutionary method and ... the use of miniature antenna modules for multiple ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Medicine researchers have discovered how new neurons born from ... the brain where they can replace old and dying ... can be specifically targeted to brain regions affected by ... Zhou and graduate student Kwan L. Ng in the ...
... last year at Petrified Forest National Park in Arizona throws ... arose more than 210 million years ago at the end ... creatures from the Late Triassic known only from their teeth, ... dinosaurs like Stegosaurus and Triceratops, which roamed the world millions ...
... science gets wiser, so do the bugs. The rates ... in the hospital have been increasing steadily in recent ... 15 issue of Clinical Infectious Diseases, now available online. ... due in part to inappropriate prescribing and overuse of ...
Cached Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 3Agilent Technologies introduces high-capacity human protein removal system for proteomics research 4Two studies document rise of superbugs in the environment 2Two studies document rise of superbugs in the environment 3
... liter of urine will give a positive reaction ... ,Certification: The Donors are of US origin ... NEGATIVE for HbsAg, HCV, HIV-1 & 2, Syphilis ... THIS MATERIAL IS SOLD FOR IN-VITRO DIAGNOSTIC USE ...
... Identical to the DH-2000, except that it ... 190-1700 nm wavelength range and comes with a ... up to 5 Hz) The DH-2000 ... spectrum of deuterium and tungsten halogen light sources ...
... pump is a dedicated cuff pump for small ... replaces manual inflation and can be used for ... mouse and rat; from single up to multi-channel ... pump has adjustable cut-off pressure in 50 mmHg ...
... These handy dispensers save space ... hats, and other garb. They are ... small parts used in labs, processing ... static charges and the particles they ...
Biology Products: